|
Biography
Suresh Mahajan, PhD. of Pulsar Ventures
Was Chief Medical Officer and Vice President of R&D of Catalytica, Inc., a successful biotechnology company that was sold in 2000 for $800 million; led development of catalytic technology platform for the pharmaceutical industry that was led to Catalyticas growth from start-up to $400 million in revenue in 5 years; over 30 years of experience in discovery and development of new technology in the pharmaceutical and chemical industries; PhD. in chemical engineering from Purdue University.
|
|